EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function

Marika Pane, Giorgia Coratti, Valeria A Sansone, Sonia Messina, Michela Catteruccia, Claudio Bruno, Maria Sframeli, Emilio Albamonte, Marina Pedemonte, Noemi Brolatti, Irene Mizzoni, Adele D'Amico and 22 more

European Journal of Neurology · 2023

DOI: 10.1111/ene.15768 ↗

At a glance

Journal article in European Journal of Neurology, 2023. Written by Marika Pane and 33 co-authors. Institution: Paediatric Neurology, Catholic University, Rome, Italy. Major MEDLINE topics: Spinal Muscular Atrophies of Childhood, Muscular Atrophy, Spinal. Cited 34 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Biogen.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

We report the 4‐year follow‐up in type I patients treated with nusinersen and the changes in motor, respiratory and bulbar function in relation to subtype, age and SMN2 copy number.

Methods

The study included SMA 1 patients with at least one assessment after 12, 24 and 48 months from the first dose of nusinersen. The assessments used were Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) and the Hammersmith Infant Neurological Examination (HINE‐II).

Results

Forty‐eight patients, with ages ranging from 7 days to 12 years (mean 3.3 years, SD 3.6 years) were included in the study. The CHOP INTEND and HINE‐II scores significantly increased between baseline and 48 months ( p < 0.001). When age at starting treatment subgroups (

Subjects

MeSH terms (MEDLINE)

Spinal Muscular Atrophies of ChildhoodMuscular Atrophy, SpinalChildInfantHumansInfant, NewbornFollow-Up StudiesOligonucleotidesNeurologic Examination

Author keywords

long-term resultslongitudinal studymotor functionnusinersenspinal muscular atrophy

Substances

nusinersenOligonucleotides

Authors and institutions

  • Paediatric Neurology, Catholic University, Rome, Italy.
  • Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
  • Neurorehabilitation Unit, University of Milan, Milan, Italy.
  • Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Center of Myology and Neurodegenerative Disorders, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Funding

  • Biogen

Cite

APA

Pane, M., Coratti, G., Sansone, V. A., Messina, S., Catteruccia, M., Bruno, C., Sframeli, M., Albamonte, E., Pedemonte, M., Brolatti, N., Mizzoni, I., D'Amico, A., Bravetti, C., Berti, B., Palermo, C., Leone, D., Salmin, F., De Sanctis, R., Pera, M. C., …, & Italian EAP Working Group (2023). Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function. European Journal of Neurology. https://doi.org/10.1111/ene.15768

Vancouver

Pane M, Coratti G, Sansone VA, Messina S, Catteruccia M, Bruno C, et al. Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function. European Journal of Neurology. 2023. doi:10.1111/ene.15768

BibTeX
@article{Pane2023,
  author = {Pane, Marika and Coratti, Giorgia and Sansone, Valeria A and Messina, Sonia and Catteruccia, Michela and Bruno, Claudio and Sframeli, Maria and Albamonte, Emilio and Pedemonte, Marina and Brolatti, Noemi and Mizzoni, Irene and D'Amico, Adele and Bravetti, Chiara and Berti, Beatrice and Palermo, Concetta and Leone, Daniela and Salmin, Francesca and De Sanctis, Roberto and Pera, Maria Carmela and Piastra, Marco and Genovese, Orazio and Ricci, Federica and Cavallina, Ilaria and Masson, Riccardo and Zanin, Riccardo and Agosto, Caterina and Salomon, Eleonora and Bruno, Irene and Magnolato, Andrea and Bertini, Enrico and Tiziano, Francesco Danilo and Bovis, Francesca and Mercuri, Eugenio and Italian EAP Working Group, Italian EAP Working Group},
  title = {Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15768}
}
Start for free →